Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571

Clinical trial NCT02127372 · TERMINATED

Trial details

NCT number: NCT02127372
Sponsor: Duke University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2004-11-01
Primary completion: 2010-06-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.